John P. Cleary

John P. Cleary

Auto-generated profile, based on publicly available information

John P. Cleary

Department of Biology, Boston University, 5 Cummington Mall, Boston, MA, 02215, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
TKTanya T. Karagiannis
Tanya T. Karagiannis
JCJohn P. Cleary
John P. Cleary
BGBusra Gok
Busra Gok
AHAndrew J. Henderson
Andrew J. Henderson
NMNicholas G. Martin
Nicholas G. Martin
CCChristine S. Cheng
Christine S. Cheng
Chronic opioid usage not only causes addiction behavior through the central nervous system, but also modulates the peripheral immune system. However, how opioid impacts the immune system is still barely characterized systematically. In order to understand the immune modulatory effect of opioids in an unbiased way, here we perform single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells from opioid-dependent individuals and controls to show that chronic opioid usage evokes widespread suppression of antiviral gene program in naive monocytes, as well as in multiple immune cell types upon stimulation with the pathogen component lipopolysaccharide. Furthermore, scRNA-seq reveals the same phenomenon after a short in vitro morphine treatment. These findings indicate that both acute and chronic opioid exposure may be harmful to our immune system by suppressing the antiviral gene program. Our results suggest that further characterization of the immune modulatory effects of opioid is critical to ensure the safety of clinical opioids.